Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127600601 | 12760060 | 1 | I | 201606 | 20160811 | 20160919 | 20160919 | EXP | CA-ELI_LILLY_AND_COMPANY-CA201608007153 | ELI LILLY AND CO | 72.17 | YR | F | Y | 0.00000 | 20160919 | CN | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127600601 | 12760060 | 1 | PS | ALIMTA | PEMETREXED DISODIUM | 1 | Intravenous (not otherwise specified) | 500 MG/M2, CYCLICAL (Q3W) | Y | 21462 | 500 | MG/M**2 | INJECTION | ||||||
| 127600601 | 12760060 | 2 | SS | ALIMTA | PEMETREXED DISODIUM | 1 | Intravenous (not otherwise specified) | 805 MG, CYCLICAL | Y | 21462 | 805 | MG | INJECTION | ||||||
| 127600601 | 12760060 | 3 | C | CARBOPLATIN. | CARBOPLATIN | 1 | Unknown | UNK, UNKNOWN | U | 0 | |||||||||
| 127600601 | 12760060 | 4 | C | APO-FOLIC ACID | FOLIC ACID | 1 | Oral | 400 UG, QD | 0 | 400 | UG | QD | |||||||
| 127600601 | 12760060 | 5 | C | VITAMIN B12 | CYANOCOBALAMIN | 1 | Subcutaneous | 1000 UG, QD | 0 | 1000 | UG | QD | |||||||
| 127600601 | 12760060 | 6 | C | CORTICOSTEROID NOS | CORTICOSTEROID NOS | 1 | Oral | 4 MG, BIDX3 DAYS | Y | 0 | 4 | MG | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127600601 | 12760060 | 1 | Non-small cell lung cancer stage IV |
| 127600601 | 12760060 | 3 | Non-small cell lung cancer |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127600601 | 12760060 | OT |
| 127600601 | 12760060 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127600601 | 12760060 | Dermatitis | |
| 127600601 | 12760060 | Lupus-like syndrome | |
| 127600601 | 12760060 | Off label use | |
| 127600601 | 12760060 | Rash generalised | |
| 127600601 | 12760060 | Skin toxicity | |
| 127600601 | 12760060 | Urinary tract infection |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127600601 | 12760060 | 1 | 20160602 | 0 | ||
| 127600601 | 12760060 | 2 | 20160614 | 0 | ||
| 127600601 | 12760060 | 4 | 20160520 | 0 | ||
| 127600601 | 12760060 | 5 | 20160520 | 0 | ||
| 127600601 | 12760060 | 6 | 20160622 | 20160624 | 0 |